Expert Matters - The Podcast

Each month, CEO of EWI, Simon Berney-Edwards, and Policy Manger, Sean Mosby, will take an informed look at developments in the world of expert witnesses and expert evidence. There will also be updates on what's happening at EWI, as well as longer form content including interviews and in-depth discussion of key issues for the expert witness community.

 

Clicking on one of the topics below will display episodes with content relevant to that topic.

 

Did you know you can get CPD hours for listening to our Podcast?

Anyone who is a registered user on our website can record their time listening to the Podcast in their CPD Log by visiting their My EWI.

Record my CPD

Pfizer Inc v Uniqure Biopharma BV [2024] EWHC 2672 (Pat)
Sean Mosby 149

Pfizer Inc v Uniqure Biopharma BV [2024] EWHC 2672 (Pat)

bySean Mosby

 

Summary

The judge in this patent case found that the claimants’ gene therapy expert had developed, quite possibly guided by lawyers, the understanding that the primary duty of an expert witness is not to say anything that may damage the instructing party’s case if it can be avoided.

To continue reading you must be an EWI member, become a member and access exclusive content. 

Already a member? Login

Share

Print
Comments are only visible to subscribers.